BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10732528)

  • 21. Symptom management in hepatocellular carcinoma.
    Sun VC; Sarna L
    Clin J Oncol Nurs; 2008 Oct; 12(5):759-66. PubMed ID: 18842532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidisciplinary management of nonresectable hepatocellular carcinoma.
    Park HC; Seong J; Tanaka M; Zeng ZC; Lim HY; Guan S; Bae SH; Tak WY
    Oncology; 2011; 81 Suppl 1():134-40. PubMed ID: 22212947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Building the multidisciplinary team for management of patients with hepatocellular carcinoma.
    Naugler WE; Alsina AE; Frenette CT; Rossaro L; Sellers MT
    Clin Gastroenterol Hepatol; 2015 May; 13(5):827-35. PubMed ID: 24909910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
    Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
    J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Prevalence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Thailand.
    Wanich N; Vilaichone RK; Chotivitayatarakorn P; Siramolpiwat S
    Asian Pac J Cancer Prev; 2016; 17(6):2857-60. PubMed ID: 27356702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shaping the future management of hepatocellular carcinoma.
    Abou-Alfa G; Colombo M
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S20-3. PubMed ID: 23457036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical resection and liver transplantation for hepatocellular carcinoma.
    Akoad ME; Pomfret EA
    Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center.
    Marcos-Alvarez A; Jenkins RL; Washburn WK; Lewis WD; Stuart KE; Gordon FD; Kane RA; Clouse ME
    Arch Surg; 1996 Mar; 131(3):292-8. PubMed ID: 8611095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resectability of hepatocellular carcinoma: evaluation of 333 consecutive cases at a single hepatobiliary specialty center and systematic review of the literature.
    Sotiropoulos GC; Lang H; Frilling A; Molmenti EP; Paul A; Nadalin S; Radtke A; Brokalaki EI; Saner F; Hilgard P; Gerken G; Broelsch CE; Malagò M
    Hepatogastroenterology; 2006; 53(69):322-9. PubMed ID: 16795964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma.
    Poon RT; Fan ST; Yu WC; Lam BK; Chan FY; Wong J
    Arch Surg; 2001 Jun; 136(6):693-9. PubMed ID: 11387012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of Cancer Care in Patients with Cirrhosis and Hepatocellular Carcinoma.
    Dhanasekaran R; Talwalkar JA
    Curr Gastroenterol Rep; 2015 Sep; 17(9):34. PubMed ID: 26238927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma.
    Rose DM; Chapman WC; Brockenbrough AT; Wright JK; Rose AT; Meranze S; Mazer M; Blair T; Blanke CD; Debelak JP; Pinson CW
    Am J Surg; 1999 May; 177(5):405-10. PubMed ID: 10365881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A Case of Hepatocellular Carcinoma with Lymph Node Metastasis Successfully Treated by Multidisciplinary Treatment].
    Soma D; Sakata J; Ando T; Yuza K; Ishikawa H; Ohashi T; Takizawa K; Takano K; Kobayashi T; Ichikawa H; Hanyu T; Nagahashi M; Shimada Y; Kameyama H; Wakai T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1565-1567. PubMed ID: 29394703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
    Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
    J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis.
    Cunningham SC; Tsai S; Marques HP; Mira P; Cameron A; Barroso E; Philosophe B; Pawlik TM
    Ann Surg Oncol; 2009 Jul; 16(7):1820-31. PubMed ID: 19267161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
    Park JW; Chen M; Colombo M; Roberts LR; Schwartz M; Chen PJ; Kudo M; Johnson P; Wagner S; Orsini LS; Sherman M
    Liver Int; 2015 Sep; 35(9):2155-66. PubMed ID: 25752327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma.
    Mohsen W; Rodov M; Prakoso E; Charlton B; Bowen DG; Koorey DJ; Shackel NA; McCaughan GW; Strasser SI
    World J Gastroenterol; 2017 Apr; 23(15):2763-2770. PubMed ID: 28487614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.